Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest Dako Stories

2013-07-16 00:20:31

LONDON, July 16, 2013 /PRNewswire/ -- A recent whitepaper created by Legal IQ uses the results of a survey of 675 IP and patent professionals globally to explore how they can monetise their IP and patent strategy. "As the 'IP for business growth' ethos expands, value creation and productivity will expand as well." - Tom Briscoe, Senior Principal Strategist of IP, Dako In order to explore and ratify our findings, Legal IQ sought the expertise...

2012-05-16 14:22:12

GRAND RAPIDS, Mich. and GLOSTRUP, Denmark, May 16, 2012 /PRNewswire/ -- Van Andel Research Institute (VARI) and Dako, the Danish-based, worldwide supplier of cancer diagnostic tools today announce an agreement to license, manufacture and distribute cancer diagnostics utilizing the MET4 Antibody. The MET4 Antibody, developed by George F. Vande Woude, Ph.D. and Brian Cao, M.D. of VARI and Beatrice Knudsen, M.D., Ph.D., formerly of the Fred Hutchinson Cancer Research Center, has...

2010-02-25 07:05:00

COPENHAGEN, Feb. 25 /PRNewswire-FirstCall/ -- SuccessFactors, Inc. (Nasdaq: SFSF) today announced that its Danish partner, Effective Learning A/S, has signed a four-year contract with Dako, a worldwide provider of cancer diagnostic solutions. Dako has deployed SuccessFactors' Business Execution (BizX) Suite to build a global, transparent high-performance culture and better execute against its global growth plans. Dako is a global leader in tissue-based cancer diagnostics and provides...

2008-06-27 03:02:32

Dako enters into collaboration with Bristol-Myers Squibb to develop clinical diagnostics to identify cancer patients who may receive greater benefits from certain drugs being developed by Bristol-Myers Squibb. Dako, a world-leading provider of cancer diagnostic solutions such as pharmDx(TM), has entered into a collaboration with Bristol-Myers Squibb Company (NYSE: BMY) to develop pharmacodiagnostic tests intended to identify patients more likely to benefit from treatment with certain...